Therapeutic agent or treatment for severe aphasia cerebrovascular disorders chronic phase

hideki   ooyama

Therapeutic agent or treatment for severe aphasia cerebrovascular disorders chronic phase

2004

hideki ooyama

Therapeutic agent for severe aphasia cerebrovascular disorders chronic phase as an active ingredient 2-oxo-1-pyrrolidineacetamide or methods of treatment.

Keywords:

Intensive care medicine
Medicine
Aphasia
Active ingredient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations